A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin Icodec

NCT05352815 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1291

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: IcoSema
DRUG: Insulin icodec

Sponsor

Novo Nordisk A/S